310 related articles for article (PubMed ID: 28318638)
1. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management.
Soliman SE; VandenHoven C; MacKeen LD; Héon E; Gallie BL
Ophthalmology; 2017 Jun; 124(6):859-872. PubMed ID: 28318638
[TBL] [Abstract][Full Text] [Related]
2. Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma.
Soliman SE; VandenHoven C; MacKeen LD; Gallie BL
Ophthalmology; 2020 Jan; 127(1):122-127. PubMed ID: 31548135
[TBL] [Abstract][Full Text] [Related]
3. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
4. Prenatal versus Postnatal Screening for Familial Retinoblastoma.
Soliman SE; Dimaras H; Khetan V; Gardiner JA; Chan HS; Héon E; Gallie BL
Ophthalmology; 2016 Dec; 123(12):2610-2617. PubMed ID: 27712844
[TBL] [Abstract][Full Text] [Related]
5. Long-term visual outcomes in intraocular retinoblastoma with eye preservation.
Batra A; Pushker N; Venkatesh P; Arora T; Tewari R; Bakhshi S
Clin Transl Oncol; 2016 Oct; 18(10):1034-8. PubMed ID: 26781471
[TBL] [Abstract][Full Text] [Related]
6. Swept-source optical coherence tomography features of regressed macular retinoblastoma.
Damodaran S; Bajaj MS; Sharma P; Kumar A; Chawla R; Pujari A; Garg G; Temkar S
Indian J Ophthalmol; 2019 Dec; 67(12):2013-2018. PubMed ID: 31755441
[TBL] [Abstract][Full Text] [Related]
7. [The first experience of using OCT in diagnosis of primary and residual retinoblastoma].
Neroev VV; Saakian SV; Miakoshina EB; Tatskov RA; Zaĭtseva OV; Riabina MV
Vestn Oftalmol; 2012; 128(2):8-12. PubMed ID: 22834231
[TBL] [Abstract][Full Text] [Related]
8. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
Soliman SE; Dimaras H; Souka AA; Ashry MH; Gallie BL
J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
[TBL] [Abstract][Full Text] [Related]
9. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
11. Management and outcome of unilateral retinoblastoma.
Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
[TBL] [Abstract][Full Text] [Related]
12. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography (OCT) to image active and inactive retinoblastomas as well as retinomas.
Nadiarnykh O; McNeill-Badalova NA; Gaillard MC; Bosscha MI; Fabius AWM; Verbraak FD; Munier FL; de Boer JF; Moll AC
Acta Ophthalmol; 2020 Mar; 98(2):158-165. PubMed ID: 31448879
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of diffuse infiltrating retinoblastoma: optical coherence tomography-assisted diagnosis and follow-up in three consecutive cases.
Stathopoulos C; Moulin A; Gaillard MC; Beck-Popovic M; Puccinelli F; Munier FL
Br J Ophthalmol; 2019 Jun; 103(6):826-830. PubMed ID: 30049803
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma: An update.
Delhiwala KS; Vadakkal IP; Mulay K; Khetan V; Wick MR
Semin Diagn Pathol; 2016 May; 33(3):133-40. PubMed ID: 26969537
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial determinants for treatment decisions in familial retinoblastoma.
Soliman SE; Ulster A; MacDonald H; VandenHoven C; Toi A; Hèon E; Gallie B
Ophthalmic Genet; 2017; 38(4):392-394. PubMed ID: 28085520
[No Abstract] [Full Text] [Related]
17. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
Malik K; Welch RJ; Shields CL
Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic).
Reddy MA; Butt M; Hinds AM; Duncan C; Price EA; Sagoo MS; Onadim Z
Ophthalmol Retina; 2021 Apr; 5(4):381-387. PubMed ID: 32835838
[TBL] [Abstract][Full Text] [Related]
19. Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation.
Soliman SE; VandenHoven C; Mackeen LD; Gallie BL
Br J Ophthalmol; 2019 Jun; 103(6):753-760. PubMed ID: 29976784
[TBL] [Abstract][Full Text] [Related]
20. Hand-held spectral-domain optical coherence tomography of small macular retinoblastoma in infants before and after chemotherapy.
Cao C; Markovitz M; Ferenczy S; Shields CL
J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):230-4. PubMed ID: 25922867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
